FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hayrettin Tumani

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Procedures

Physiology

Occupations

Proteomics

Anatomy

Cerebrospinal Fluid

Co-author Network

Publications

TOP 3
Martin Stangel; Olaf Stüve; Sten Fredrikson; Edgar Meinl; Axel Petzold; Hayrettin Tumani
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
Valérie Jolivel; Helmut Jonuleit; Sabrina Klebow; Stefan H P Kraus; Felix Luessi; Joumana Masri; Magdalena Paterka; Laura Poisa-Beiro; Volker Siffrin; Hayrettin Tumani; Roberto Furlan; Mario Hubo; Nir Yogev; Frauke Zipp; Ari Waisman
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Sigurd D Süssmuth; M Wick; Johannes Brettschneider; S Jesse; J Lewerenz; M Otto; A Spreer; Hayrettin Tumani
[Current cerebrospinal fluid diagnostics for pathogen-related diseases].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hayrettin Tumani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin Stangel; Olaf Stüve; Sten Fredrikson; Edgar Meinl; Axel Petzold; Hayrettin Tumani
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
Nature reviews. Neurology 2013;9(5):267-76.
2013: Valérie Jolivel; Helmut Jonuleit; Sabrina Klebow; Stefan H P Kraus; Felix Luessi; Joumana Masri; Magdalena Paterka; Laura Poisa-Beiro; Volker Siffrin; Hayrettin Tumani; Roberto Furlan; Mario Hubo; Nir Yogev; Frauke Zipp; Ari Waisman
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Brain : a journal of neurology 2013;136(Pt 4):1048-66.
2013: Sigurd D Süssmuth; M Wick; Johannes Brettschneider; S Jesse; J Lewerenz; M Otto; A Spreer; Hayrettin Tumani
[Current cerebrospinal fluid diagnostics for pathogen-related diseases].
Der Nervenarzt 2013;84(2):229-44.
2012: Nenad Vasic; Robert C Wolf; Bernhard Connemann; Hayrettin Tumani; Johannes Brettschneider
Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?
European archives of psychiatry and clinical neuroscience 2012;262(5):375-91.
2012: Stefan Lehnert; Martin Lenter; Patrick Oeckl; Boris Ferger; Bastian Hengerer; Sanna-Kaisa Herukka; Sarah Jesse; Wolfgang Rist; Hilkka Soininen; Petra Steinacker; Hayrettin Tumani; Markus Otto
iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia.
Experimental neurology 2012;234(2):499-505.
2012: Thomas Korn; Hayrettin Tumani
Patterns of intrathecal autoreactive antibodies in MS using antigen microarrays.
Neurology 2012;78(8):522-3.
2012: Sarah Jesse; Hans A Kretzschmar; Hasan Kulaksiz; Stefan Lehnert; Martin Lenter; Manuela Neumann; Boris Ferger; Bastian Hengerer; Sanna-Kaisa Herukka; Olaf Jahn; Lucilla Parnetti; Hilkka Soininen; Petra Steinacker; Saskia Tawfik; Hayrettin Tumani; Christine A F Von Arnim; Jens Wiltfang; Markus Otto
Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.
PloS one 2012;7(11):e48783.
2012: Hayrettin Tumani; Johannes Brettschneider
Biochemical markers of autoimmune diseases of the nervous system.
Current pharmaceutical design 2012;18(29):4556-63.
2012: Markus Otto; Lucilla Parnetti; Axel Petzold; Pamela Shaw; Alexander Sherman; Petra Steinacker; Sigurd D Süssmuth; Charlotte Teunissen; Hayrettin Tumani; Martin Turner; Anna Wuolikainen; James Berry; Robert Bowser; Johannes Brettschneider; James Connor; Júlia Costa; Merit Cudkowicz; Jonathan Glass; Olaf Jahn; Stefan Lehnert; Albert Ludolph; Andrea Malaspina
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2012;13(1):1-10.
2012: Elena Lebedeva; Albert C Ludolph; Markus Otto; Esra Özer; Matthias W Riepe; Julia C Stingl; Joachim Strauss; Dietmar R Thal; Hayrettin Tumani; Lars Bertram; Estifanos Ghebremedhin; Josef Högel; Björn von Einem; Christine A F Von Arnim
Genetic variants in PSEN2 and correlation to CSF β-amyloid42 levels in AD.
Neurobiology of aging 2012;33(1):201.e9-18.
2011: Ulf Ziemann; Mathias Wahl; Elke Hattingen; Hayrettin Tumani
Development of biomarkers for multiple sclerosis as a neurodegenerative disorder.
Progress in neurobiology 2011;95(4):670-85.
2011: Ingo Uttner; Christine A F Von Arnim; Johannes Brettschneider; Christian Lange-Asschenfeldt; Matthias W Riepe; Niklas Schurig; Hayrettin Tumani
Amyloid beta 1-42 in cerebrospinal fluid is associated with cognitive plasticity.
Psychiatry research 2011;190(1):132-6.
2011: Hayrettin Tumani; Brigitte Wildemann; Florian Deisenhammer; Gavin Giovannoni; Ralf Gold; Hans-Peter Hartung; Bernhard Hemmer; Reinhard Hohlfeld; Markus Otto; Martin Stangel; Uwe K Zettl
Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis.
Annals of neurology 2011;70(3):520; author reply 521.
2011: Sarah Jesse; Johannes Brettschneider; Sigurd D Süssmuth; Bernhard G Landwehrmeyer; Christine A F Von Arnim; Albert C Ludolph; Hayrettin Tumani; Markus Otto
Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases.
Journal of neurology 2011;258(6):1034-41.
2011: Hayrettin Tumani; Diego Cadavid
Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?
Neurology 2011;76(12):1034-5.
2011: Brit-Maren M Schjeide; Cathrin Schnack; Jean-Charles Lambert; Christina M Lill; Julia Kirchheiner; Hayrettin Tumani; Markus Otto; Rudolph E Tanzi; Hans Lehrach; Philippe Amouyel; Christine A F Von Arnim; Lars Bertram
The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels.
Archives of general psychiatry 2011;68(2):207-13.
2011: Charlotte E Teunissen; Hayrettin Tumani; Vincent van Pesch; Emmanuelle Waubant; Christian Wolf; Jeffrey L Bennett; Frode S Berven; Lou Brundin; Manuel Comabella; Florian Deisenhammer; Jette L Federiksen; John O Fleming; Diego Franciotta; Roberto Furlan; Gavin Giovannoni; Rogier Q Hintzen; Steven Hughes; Connie R Jimenez; Michael H Johnson; Joep Killestein; Eva Krasulova; Jens Kuhle; Maria Chiara Magnone; Axel Petzold; Cecilia Rajda; Konrad Rejdak; Hollie K Schmidt; Bernhard Hemmer
Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.
Multiple sclerosis international 2011;2011():246412.
2011: Petra Steinacker; Hayrettin Tumani; Lubin Fang; Jens Kuhle; Albert C Ludolph; Markus Otto; Axel Petzold; Johannes Brettschneider
Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
PloS one 2011;6(8):e23600.
2011: Hayrettin Tumani; Jan Kassubek; Mohammed Hijazi; Vera Lehmensiek; Alexander Unrath; Sigurd D Süssmuth; Florian Lauda; Tamara Kapfer; Lubin Fang; Makbule Senel; Johannes Brettschneider
Patterns of TH1/TH2 cytokines predict clinical response in multiple sclerosis patients treated with glatiramer acetate.
European neurology 2011;65(3):164-9.
2011: Johannes Brettschneider; Nele Hartmann; Vera Lehmensiek; Helga Mogel; Albert C Ludolph; Hayrettin Tumani
Cerebrospinal fluid markers of idiopathic intracranial hypertension: is the renin-angiotensinogen system involved?
Cephalalgia : an international journal of headache 2011;31(1):116-21.
2010: Johann Sellner; Sabine Cepok; Sudhakar Reddy Kalluri; Axel Nestler; Ingo Kleiter; Tania Kümpfel; Ralf Linker; Arthur Melms; Til Menge; Hayrettin Tumani; Friedemann Paul; Bernhard Hemmer; Achim Berthele
Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses.
Neurochemistry international 2010;57(6):662-7.
2010: Hela-Felicitas Petereit; Dirk Reske; Hayrettin Tumani; Sven Jarius; F Markus Leweke; Dirk Woitalla; Hans-Walter Pfister; Andrea Rubbert
Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis.
Journal of neurology 2010;257(11):1855-63.
2010: Ingo Uttner; Niklas Schurig; Christine A F Von Arnim; Christian Lange-Asschenfeldt; Hayrettin Tumani; Matthias W Riepe
Reduced benefit from mnemonic strategies in early-stage Alzheimer's disease: a brief testing-the-limits paradigm for clinical practice.
Journal of neurology 2010;257(10):1718-26.
2010: Hayrettin Tumani; Axel Petzold; M Wick; H-J Kühn; M Uhr; M Otto; A Regeniter; Johannes Brettschneider
[Cerebrospinal fluid-based diagnostics of CT-negative subarachnoid haemorrhage].
Der Nervenarzt 2010;81(8):973-9.
2010: Makbule Senel; Tobias A Rupprecht; Hayrettin Tumani; Hans W Pfister; Albert C Ludolph; Johannes Brettschneider
The chemokine CXCL13 in acute neuroborreliosis.
Journal of neurology, neurosurgery, and psychiatry 2010;81(8):929-33.
2010: Sigurd D Süssmuth; Ingo Uttner; Bernhard Landwehrmeyer; Elmar H Pinkhardt; Johannes Brettschneider; Axel Petzold; Bernd Kramer; Jörg B Schulz; Christian Palm; Markus Otto; Albert C Ludolph; Jan Kassubek; Hayrettin Tumani
Differential pattern of brain-specific CSF proteins tau and amyloid-β in Parkinsonian syndromes.
Movement disorders : official journal of the Movement Disorder Society 2010;25(9):1284-8.
2010: Lubin Fang; Marko Teuchert; Friederike Huber-Abel; Dagmar Schattauer; Corinna Hendrich; Johannes Dorst; Heinz Zettlmeissel; Meinhard Wlaschek; Karin Scharffetter-Kochanek; Tamara Kapfer; Hayrettin Tumani; Albert C Ludolph; Johannes Brettschneider
MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS.
Journal of the neurological sciences 2010;294(1-2):51-6.
2010: Sigurd D Süssmuth; Anne-Dorte Sperfeld; Albert C Ludolph; Hayrettin Tumani
Hypercapnia is a possible determinant of the function of the blood-cerebrospinal fluid barrier in amyotrophic lateral sclerosis.
Neurochemical research 2010;35(7):1071-4.
2010: Karl Bechter; H Reiber; Sibylle Herzog; D Fuchs; Hayrettin Tumani; H G Maxeiner
Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction.
Journal of psychiatric research 2010;44(5):321-30.
2010: Sigurd D Süssmuth; Anne-Dorte Sperfeld; A Hinz; Johannes Brettschneider; S Endruhn; Albert C Ludolph; Hayrettin Tumani
CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Neurology 2010;74(12):982-7.
2010: Hayrettin Tumani; Vera Lehmensiek; Stefan Lehnert; Markus Otto; Johannes Brettschneider
2D DIGE of the cerebrospinal fluid proteome in neurological diseases.
Expert review of proteomics 2010;7(1):29-38.
2010: Petra Steinacker; Hans Klafki; Stefan Lehnert; Sarah Jesse; Christine A F V Arnim; Hayrettin Tumani; Alice Pabst; Hans A Kretzschmar; Jens Wiltfang; Markus Otto
ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients.
Journal of Alzheimer's disease : JAD 2010;22(1):119-28.
2010: Matthias W Riepe; Johann Karl; Hayrettin Tumani; Christine A F Von Arnim
Tau-proteins as gender-specific state markers in amnestic mild cognitive impairment.
Dementia and geriatric cognitive disorders 2010;30(2):93-100.
2010: Johannes Brettschneider; Anne Czerwoniak; Makbule Senel; Lubin Fang; Jan Kassubek; Elmar Pinkhardt; Florian Lauda; Tamara Kapfer; Sarah Jesse; Vera Lehmensiek; Albert C Ludolph; Markus Otto; Hayrettin Tumani
The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).
PloS one 2010;5(8):e11986.
2010: Sarah Jesse; Petra Steinacker; Stefan Lehnert; Martin Sdzuj; Lukas Cepek; Hayrettin Tumani; Olaf Jahn; Holger Schmidt; Markus Otto
A proteomic approach for the diagnosis of bacterial meningitis.
PloS one 2010;5(4):e10079.
2010: Petra Steinacker; Wolfgang Rist; Magdalena Swiatek-de Lange; Stefan Lehnert; Sarah Jesse; Alice Pabst; Hayrettin Tumani; Christine A F Von Arnim; Eva Mitrova; Hans A Kretzschmar; Martin Lenter; Jens Wiltfang; Markus Otto
Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.
Proteomics 2010;10(1):81-9.
2010: Johannes Brettschneider; Vera Lehmensiek; Helga Mogel; Martin Pfeifle; Johannes Dorst; Corinna Hendrich; Albert C Ludolph; Hayrettin Tumani
Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS).
Neuroscience letters 2010;468(1):23-7.
2009: Johannes Brettschneider; Troy D Jaskowski; Hayrettin Tumani; Sana Abdul; Dee Husebye; Haniah Seraj; Harry R Hill; Ella Fire; Larissa Spector; Jennifer Yarden; Nir Dotan; John W Rose
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
Journal of neuroimmunology 2009;217(1-2):95-101.
2009: Hayrettin Tumani; Irina Sapunova-Mayer; Sigurd D Süssmuth; Valerie Hirt; Johannes Brettschneider
CIS case studies.
Journal of the neurological sciences 2009;287 Suppl 1():S7-10.
2009: Lubin Fang; Friederike Huber-Abel; Marko Teuchert; Corinna Hendrich; Johannes Dorst; Dagmar Schattauer; Heinz Zettlmeissel; Meinhard Wlaschek; Karin Scharffetter-Kochanek; Hayrettin Tumani; Albert C Ludolph; Johannes Brettschneider
Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
Journal of the neurological sciences 2009;285(1-2):62-6.
2009: Hayrettin Tumani; Martin Pfeifle; Vera Lehmensiek; Daniela Rau; Helga Mogel; Albert C Ludolph; Johannes Brettschneider
Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid.
Journal of neuroimmunology 2009;214(1-2):109-12.
2009: Petra Steinacker; Corinna Hendrich; Anne-Dorte Sperfeld; Sarah Jesse; Stefan Lehnert; Alice Pabst; Christine A F Von Arnim; Felix M Mottaghy; Ingo Uttner; Hayrettin Tumani; Albert Ludolph; Markus Otto
Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Journal of neural transmission (Vienna, Austria : 1996) 2009;116(9):1169-78.
2009: Hayrettin Tumani; Hans-Peter Hartung; Bernhard Hemmer; Charlotte Teunissen; Florian Deisenhammer; Gavin Giovannoni; Uwe K Zettl
Cerebrospinal fluid biomarkers in multiple sclerosis.
Neurobiology of disease 2009;35(2):117-27.
2009: Michael J Schmeisser; Alexander Unrath; Markus Otto; Hayrettin Tumani; Birgit Abler
Moyamoya disease precipitating Sydenham's chorea in a 19-year-old Caucasian woman.
Movement disorders : official journal of the Movement Disorder Society 2009;24(9):1401-3.
2009: Hayrettin Tumani; Vera Lehmensiek; D Rau; I Guttmann; G Tauscher; H Mogel; C Palm; V Hirt; S D Suessmuth; I Sapunova-Meier; Albert C Ludolph; Johannes Brettschneider
CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
Neuroscience letters 2009;452(2):214-7.
2009: Ingo Uttner; Hayrettin Tumani; Christine von Arnim; Johannes Brettschneider
Cognitive impairment in superficial siderosis of the central nervous system: a case report.
Cerebellum (London, England) 2009;8(1):61-3.
2009: Johannes Brettschneider; Hayrettin Tumani; Ulrike Kiechle; Rainer Muche; Gayle Richards; Vera Lehmensiek; Albert C Ludolph; Markus Otto
IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome.
PloS one 2009;4(11):e7638.
2009: Ralf A Linker; Peter Brechlin; Sarah Jesse; Petra Steinacker; D H Lee; Abdul R Asif; Olaf Jahn; Hayrettin Tumani; Ralf Gold; Markus Otto
Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage.
PloS one 2009;4(10):e7624.
2009: Sarah Jesse; Petra Steinacker; Lukas Cepek; Christine A F Von Arnim; Hayrettin Tumani; Stefan Lehnert; Hans A Kretzschmar; Michael Baier; Markus Otto
Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
Journal of Alzheimer's disease : JAD 2009;17(3):541-51.
2009: Johannes Brettschneider; Axel Petzold; Sigurd Süssmuth; Hayrettin Tumani
Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?
Journal of neurology 2009;256(1):3-12.
2009: Horst-G Maxeiner; Markus Thomas Rojewski; Anita Schmitt; Hayrettin Tumani; Karl Bechter; Michael Schmitt
Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.
Brain, behavior, and immunity 2009;23(1):134-42.
2008: Hayrettin Tumani
Corticosteroids and plasma exchange in multiple sclerosis.
Journal of neurology 2008;255 Suppl 6():36-42.
2008: Petra Steinacker; Corinna Hendrich; Anne-Dorte Sperfeld; Sarah Jesse; Christine A F Von Arnim; Stefan Lehnert; Alice Pabst; Ingo Uttner; Hayrettin Tumani; Virginia M-Y Lee; John Q Trojanowski; Hans A Kretzschmar; Albert C Ludolph; Manuela Neumann; Markus Otto
TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Archives of neurology 2008;65(11):1481-7.
2008: Johannes Brettschneider; Helga Mogel; Vera Lehmensiek; Tino Ahlert; Sigurd D Süssmuth; Albert C Ludolph; Hayrettin Tumani
Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS).
Neurochemical research 2008;33(11):2358-63.
2008: Hayrettin Tumani; Charlotte Teunissen; Sigurd D Süssmuth; Markus Otto; Albert C Ludolph; Johannes Brettschneider
Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.
Expert review of molecular diagnostics 2008;8(4):479-94.
2008: Anastassia Gontsarova; Eckhard Kaufmann; Hayrettin Tumani; Alexander Dressel; Friedrich Mandel; Karl-Heinz Wiesmüller; Christiane Kunert-Keil; Heinrich Brinkmeier
Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid.
Clinica chimica acta; international journal of clinical chemistry 2008;389(1-2):152-9.
2008: Alexander Storch; Vsevolod A Vladimirtsev; Hayrettin Tumani; Nele Wellinghausen; Alois Haas; Vadim G Krivoshapkin; Albert C Ludolph
Viliuisk encephalomyelitis in Northeastern Siberia is not caused by Borrelia burgdorferi infection.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2008;29(1):11-4.
2008: Sigurd D Süssmuth; Johannes Brettschneider; Albert C Ludolph; Hayrettin Tumani
Biochemical markers in CSF of ALS patients.
Current medicinal chemistry 2008;15(18):1788-801.
2008: U Beinhoff; Hayrettin Tumani; Johannes Brettschneider; Daniel Bittner; Matthias W Riepe
Gender-specificities in Alzheimer's disease and mild cognitive impairment.
Journal of neurology 2008;255(1):117-22.
2007: Vera Lehmensiek; Sigurd D Süssmuth; G Tauscher; Johannes Brettschneider; S Felk; F Gillardon; Hayrettin Tumani
Cerebrospinal fluid proteome profile in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(7):840-9.
2007: Karin Widl; Johannes Brettschneider; Dagmar Schattauer; Sigurd D Süssmuth; Roman Huber; Albert C Ludolph; Hayrettin Tumani
Erythropoietin in cerebrospinal fluid: age-related reference values and relevance in neurological disease.
Neurochemical research 2007;32(7):1163-8.
2007: Hayrettin Tumani; Ingo Uttner
Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis.
Journal of neurology 2007;254 Suppl 2():II69-72.
2007: Johannes Brettschneider; Karin Widl; Dagmar Schattauer; Albert C Ludolph; Hayrettin Tumani
Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
Neuroscience letters 2007;416(3):257-60.
2007: Vera Lehmensiek; Sigurd D Süssmuth; Johannes Brettschneider; G Tauscher; S Felk; F Gillardon; Hayrettin Tumani
Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS).
Journal of neuroimmunology 2007;185(1-2):190-4.
2006: Alexander Dressel; A K Kolb; Ercan Elitok; Andreas Bitsch; Timon Bogumil; Bernd Kitze; Hayrettin Tumani; Frank Weber
Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.
Acta neurologica Scandinavica 2006;114(6):368-73.
2006: Johannes Brettschneider; Axel Petzold; Sigurd D Süssmuth; G Bernhard Landwehrmeyer; Albert C Ludolph; Jan Kassubek; Hayrettin Tumani
Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2224-7.
2006: Piotr Lewczuk; Georg Beck; Oliver Ganslandt; Hermann Esselmann; Florian Deisenhammer; Axel Regeniter; Hela-Felicitas Petereit; Hayrettin Tumani; Andreas Gerritzen; Patrick Oschmann; Johannes Schröder; Peter Schönknecht; Klaus Zimmermann; Harald Hampel; Katharina Bürger; Markus Otto; Sabine Haustein; Karin Herzog; Rainer Dannenberg; Ulrich Wurster; Mirko Bibl; Juan Manuel Maler; Udo Reubach; Johannes Kornhuber; Jens Wiltfang
International quality control survey of neurochemical dementia diagnostics.
Neuroscience letters 2006;409(1):1-4.
2006: Hayrettin Tumani
Rare indications of IVIG therapy in neurological diseases based on case reports and small studies.
Journal of neurology 2006;253 Suppl 5():V66-9.
2006: Johannes Brettschneider; Karin Widl; Hannelore Ehrenreich; Matthias W Riepe; Hayrettin Tumani
Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.
Neuroscience letters 2006;404(3):347-51.
2006: Ingo Uttner; Hayrettin Tumani
[Effects of high-dose cortisone therapy on cognition].
Der Nervenarzt 2006;77(6):647-8, 650-1.
2006: Johannes Brettschneider; Axel Petzold; Andreas Junker; Hayrettin Tumani
Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(2):143-8.
2006: Johannes Brettschneider; Axel Petzold; Sigurd D Süssmuth; Albert C Ludolph; Hayrettin Tumani
Axonal damage markers in cerebrospinal fluid are increased in ALS.
Neurology 2006;66(6):852-6.
2006: Johannes Brettschneider; Axel Petzold; Daniel Schottle; Annett Claus; Matthias W Riepe; Hayrettin Tumani
The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease.
Dementia and geriatric cognitive disorders 2006;21(5-6):291-5.
2005: Hartmut Selle; Jens Lamerz; Katharina Buerger; Andreas Dessauer; Klaus Hager; Harald Hampel; Johann Karl; Markus Kellmann; Lars Lannfelt; Jukka Louhija; Matthias W Riepe; Wolfgang Rollinger; Hayrettin Tumani; Michael Schrader; Hans-Dieter Zucht
Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease.
Combinatorial chemistry & high throughput screening 2005;8(8):801-6.
2005: Wolfgang Jordan; Hayrettin Tumani; Stefan Cohrs; Andrea Rodenbeck; Eckart Rüther; Jens Bechthold; Geert Mayer
Narcolepsy increased L-PGDS (beta-trace) levels correlate with excessive daytime sleepiness but not with cataplexy.
Journal of neurology 2005;252(11):1372-8.
2005: Johannes Brettschneider; Annett Claus; Jan Kassubek; Hayrettin Tumani
Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.
Journal of neurology 2005;252(9):1067-73.
2005: Ingo Uttner; S Müller; C Zinser; M Maier; Sigurd D Süssmuth; Annett Claus; B Ostermann; Ercan Elitok; Daniel Ecker; Johannes Brettschneider; R Gold; Hayrettin Tumani
Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.
Neurology 2005;64(11):1971-3.
2005: Johannes Brettschneider; M Maier; S Arda; Annett Claus; Sigurd D Süssmuth; Jan Kassubek; Hayrettin Tumani
Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(3):261-5.
2005: Carlos Schönfeldt-Lecuona; Roland W Freudenmann; Hayrettin Tumani; Jan Kassubek; Bernhard Connemann
Acute psychosis with a mediastinal carcinoma metastasis.
Medical science monitor : international medical journal of experimental and clinical research 2005;11(1):CS6-8.
2004: Andreas Bitsch; Alexander Dressel; Kathrin Meier; Timon Bogumil; Florian Deisenhammer; Hayrettin Tumani; Bernd Kitze; Sigrid Poser; Frank Weber
Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b.
Journal of neurology 2004;251(12):1498-501.
2004: Andreas Bitsch; Dirk Bahner; C Wachter; Ercan Elitok; Timon Bogumil; Alexander Dressel; T Polak; Hayrettin Tumani; Frank Weber; Sigrid Poser; Bernd Kitze
Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis.
Acta neurologica Scandinavica 2004;110(6):386-92.
2004: Eckhard Kaufmann; Bernhard O Boehm; Sigurd D Süssmuth; Rosemarie Kientsch-Engel; Anne-Dorte Sperfeld; Albert C Ludolph; Hayrettin Tumani
The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Neuroscience letters 2004;371(2-3):226-9.
2004: Johannes Brettschneider; Matthias W Riepe; Hela-Felicitas Petereit; Albert C Ludolph; Hayrettin Tumani
Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus?
Journal of neurology, neurosurgery, and psychiatry 2004;75(11):1614-6.
2004: Wolfgang Jordan; Hayrettin Tumani; Stefan Cohrs; Sebastian Eggert; Andrea Rodenbeck; Edgar Brunner; Eckart Rüther; Göran Hajak
Prostaglandin D synthase (beta-trace) in healthy human sleep.
Sleep 2004;27(5):867-74.
2003: Sigurd D Süssmuth; Hayrettin Tumani; Daniel Ecker; Albert C Ludolph
Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum.
Neuroscience letters 2003;353(1):57-60.
2003: Maryna Yushchenko; Michael Mäder; Ercan Elitok; Andreas Bitsch; Alexander Dressel; Hayrettin Tumani; Timon Bogumil; Bernd Kitze; Sigrid Poser; Frank Weber
Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
Journal of neurology 2003;250(10):1224-8.
2003: Jan Kassubek; Hayrettin Tumani; Daniel Ecker; Anja Kurt; Albert C Ludolph; Freimut D Juengling
Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study.
Neuroreport 2003;14(3):427-30.
2002: Johannes Brettschneider; Daniel Ecker; Andreas Bitsch; Dirk Bahner; Timon Bogumil; Alexander Dressel; Ercan Elitok; Bernd Kitze; S Poser; Frank Weber; Hayrettin Tumani
The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b.
Journal of neuroimmunology 2002;133(1-2):193-7.
2002: Wolfgang Jordan; J Hagedohm; Jörg Wiltfang; G Laier-Groeneveld; Hayrettin Tumani; Andrea Rodenbeck; Eckart Rüther; Göran Hajak
Biochemical markers of cerebrovascular injury in sleep apnoea syndrome.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2002;20(1):158-64.
2002: Dirk Bahner; Christine Klucke; Bernd Kitze; Ercan Elitok; Timon Bogumil; Alexander Dressel; Hayrettin Tumani; Frank Weber; Sigrid Poser; Andreas Bitsch
Interferon-beta-1b increases serum interleukin-12 p40 levels in primary progressive multiple sclerosis patients.
Neuroscience letters 2002;326(2):125-8.
2002: Hayrettin Tumani; O Windl; Hans A Kretzschmar; A C Ludolph
[Clinically atypical CJD: diagnostic relevance of cerebrospinal fluid markers and molecular genetic analysis?].
Deutsche medizinische Wochenschrift (1946) 2002;127(7):318-20.
2001: Sigurd D Süssmuth; Hansotto Reiber; Hayrettin Tumani
Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases.
Neuroscience letters 2001;300(2):95-8.
2000: Maryna Yushchenko; Frank Weber; Michael Mäder; Ulrike Schöll; M Maliszewska; Hayrettin Tumani; K Felgenhauer; Wolfgang Beuche
Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count.
Journal of neuroimmunology 2000;110(1-2):244-51.
2000: D Dabbert; S Rösner; M Krämer; Ulrike Schöll; Hayrettin Tumani; Michael Mäder; Frank Weber
Glatiramer acetate (copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein.
Neuroscience letters 2000;289(3):205-8.
2000: Hayrettin Tumani; Alexandr Smirnov; S Barchfeld; U Olgemöller; K Maier; Peter Lange; Wolfgang Brück; Roland Nau
Inhibition of glutamine synthetase in rabbit pneumococcal meningitis is associated with neuronal apoptosis in the dentate gyrus.
Glia 2000;30(1):11-8.
2000: A V Smirnov; Hayrettin Tumani; S Henne; S Barchfeld; U Olgemöller; Jens Wiltfang; Peter Lange; Michael Mäder; Roland Nau
Glutamine synthetase in experimental meningitis: increased ratio of the subunits 3 and 2 may indicate enhanced activity.
Clinica chimica acta; international journal of clinical chemistry 2000;292(1-2):1-12.
1999: Hayrettin Tumani; G Shen; JB Peter; Wolfgang Brück
Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?
Archives of neurology 1999;56(10):1241-6.
1999: M Bargfrede; A Schwennicke; Hayrettin Tumani; Carl Detlev Reimers
Quantitative ultrasonography in focal neuropathies as compared to clinical and EMG findings.
European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology 1999;10(1):21-9.
1999: B Blödorn; Wolfgang Brück; Hayrettin Tumani; Uwe Michel; P Rieckmann; N Althans; Michael Mäder
Expression of the beta-trace protein in human pachymeninx as revealed by in situ hybridization and immunocytochemistry.
Journal of neuroscience research 1999;57(5):730-4.
1999: Bernhard J Steinhoff; Hayrettin Tumani; M Otto; Kay Mursch; Jörg Wiltfang; Gregor Herrendorf; Hans-Joachim Bittermann; K Felgenhauer; Walter Paulus; Evagelos Markakis
Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy.
Epilepsy research 1999;36(1):75-82.
1999: Hayrettin Tumani; M Otto; Olaf Gefeller; Jörg Wiltfang; Gregor Herrendorf; S Mogge; Bernhard J Steinhoff
Kinetics of serum neuron-specific enolase and prolactin in patients after single epileptic seizures.
Epilepsia 1999;40(6):713-8.
1998: Joachim Gerber; Hayrettin Tumani; Herbert Kolenda; Roland Nau
Lumbar and ventricular CSF protein, leukocytes, and lactate in suspected bacterial CNS infections.
Neurology 1998;51(6):1710-4.
1998: Hayrettin Tumani; Roland Nau; K Felgenhauer
Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases.
Annals of neurology 1998;44(6):882-9.
1998: Piotr Lewczuk; Hansotto Reiber; Hayrettin Tumani
Intercellular adhesion molecule-1 in cerebrospinal fluid--the evaluation of blood-derived and brain-derived fractions in neurological diseases.
Journal of neuroimmunology 1998;87(1-2):156-61.
1998: Hayrettin Tumani; W W Tourtellotte; JB Peter; K Felgenhauer
Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Journal of the neurological sciences 1998;155(1):44-9.
1998: Hayrettin Tumani; Hansotto Reiber; Roland Nau; Hilmar Prange; K Kauffmann; Michael Mäder; K Felgenhauer
Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis.
Neuroscience letters 1998;242(1):5-8.
1997: R Poethke; Hayrettin Tumani; K Felgenhauer; Michael Mäder
Establishment of an efficient enzyme-linked immunosorbent assay for the determination of human choline acetyltransferase.
Journal of neuroimmunology 1997;76(1-2):206-12.
1997: Markus Otto; Jens Wiltfang; Hayrettin Tumani; Inga Zerr; M Lantsch; Johannes Kornhuber; T Weber; Hans A Kretzschmar; Sigrid Poser
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
Neuroscience letters 1997;225(3):210-2.
1997: Hayrettin Tumani; A George; Roland Nau
[Myasthenic crisis caused by azathioprine-induced fever].
Der Nervenarzt 1997;68(4):336-8.
1997: Argyrios K Stringaris; Wolfgang Brück; Hayrettin Tumani; Hauke Schmidt; Roland Nau
Increased glutamine synthetase immunoreactivity in experimental pneumococcal meningitis.
Acta neuropathologica 1997;93(3):215-8.
1995: Hayrettin Tumani; G Nölker; Hansotto Reiber
Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis.
Neurology 1995;45(9):1663-70.
1995: Peter Rieckmann; M Albrecht; Bernd Kitze; T Weber; Hayrettin Tumani; Andreas Broocks; W Lüer; A Helwig; Sigrid Poser
Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.
Annals of neurology 1995;37(1):82-8.
1994: Peter Rieckmann; Stephan Martin; I Weichselbraun; M Albrecht; Bernd Kitze; T Weber; Hayrettin Tumani; Andreas Broocks; W Lüer; A Helwig
Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse.
Neurology 1994;44(12):2367-72.
1994: Peter Rieckmann; M Albrecht; Bernd Kitze; T Weber; Hayrettin Tumani; Andreas Broocks; W Lüer; Sigrid Poser
Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis.
Neurology 1994;44(8):1523-6.
1993: T Weber; Hayrettin Tumani; B Holdorff; J Collinge; M Palmer; Hans A Kretzschmar; K Felgenhauer
Transmission of Creutzfeldt-Jakob disease by handling of dura mater.
Lancet 1993;341(8837):123-4.